| Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus W Yang, N Shen, DQ Ye, Q Liu, Y Zhang, XX Qian, N Hirankarn, D Ying, ... PLoS genetics 6 (2), e1000841, 2010 | 458 | 2010 |
| Collapsing glomerulopathy in a COVID-19 patient S Kissling, S Rotman, C Gerber, M Halfon, F Lamoth, D Comte, ... Kidney international 98 (1), 228-231, 2020 | 355 | 2020 |
| Polyfunctional HCV‐specific T‐cell responses are associated with effective control of HCV replication D Ciuffreda, D Comte, M Cavassini, E Giostra, L Bühler, M Perruchoud, ... European journal of immunology 38 (10), 2665-2677, 2008 | 164 | 2008 |
| Adverse reactions to biologic agents and their medical management O Boyman, D Comte, F Spertini Nature Reviews Rheumatology 10 (10), 612-627, 2014 | 133 | 2014 |
| T cells as a therapeutic target in SLE D Comte, MP Karampetsou, GC Tsokos Lupus 24 (4-5), 351-363, 2015 | 116 | 2015 |
| Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders M Perreau, S Vigano, F Bellanger, C Pellaton, G Buss, D Comte, T Roger, ... Journal of Experimental Medicine 211 (10), 2033-2045, 2014 | 113 | 2014 |
| CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression S Vigano, R Banga, F Bellanger, C Pellaton, A Farina, D Comte, A Harari, ... PLoS pathogens 10 (9), e1004380, 2014 | 86 | 2014 |
| ICER is requisite for Th17 differentiation N Yoshida, D Comte, M Mizui, K Otomo, F Rosetti, TN Mayadas, ... Nature communications 7 (1), 12993, 2016 | 80 | 2016 |
| Differences in HCV‐specific T cell responses between chronic HCV infection and HIV/HCV co‐infection V Dutoit, D Ciuffreda, D Comte, JJ Gonvers, G Pantaleo European journal of immunology 35 (12), 3493-3504, 2005 | 80 | 2005 |
| The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients M Perreau, M Suffiotti, P Marques-Vidal, A Wiedemann, Y Levy, ... Nature Communications 12 (1), 4888, 2021 | 76 | 2021 |
| Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity T Katsuyama, H Li, D Comte, GC Tsokos, VR Moulton The Journal of clinical investigation 129 (12), 5411-5423, 2019 | 68 | 2019 |
| Selective loss of signaling lymphocytic activation molecule family member 4–positive CD8+ T cells contributes to the decreased cytotoxic cell activity in systemic lupus … K Kis‐Toth, D Comte, MP Karampetsou, VC Kyttaris, L Kannan, C Terhorst, ... Arthritis & rheumatology 68 (1), 164-173, 2016 | 61 | 2016 |
| Signaling lymphocytic activation molecule family member 7 engagement restores defective effector CD8+ T cell function in systemic lupus erythematosus D Comte, MP Karampetsou, N Yoshida, K Kis‐Toth, VC Kyttaris, ... Arthritis & rheumatology 69 (5), 1035-1044, 2017 | 59 | 2017 |
| Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin‐2 D Comte, MP Karampetsou, K Kis‐Toth, N Yoshida, SJ Bradley, ... Arthritis & rheumatology 69 (4), 808-813, 2017 | 56 | 2017 |
| Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus D Comte, MP Karampetsou, K Kis-Toth, N Yoshida, SJ Bradley, M Mizui, ... Proceedings of the National Academy of Sciences 113 (33), 9321-9326, 2016 | 38 | 2016 |
| Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult A Othenin-Girard, J Regamey, F Lamoth, A Horisberger, E Glampedakis, ... Swiss medical weekly 150 (4546), w20387-w20387, 2020 | 35 | 2020 |
| Innate lymphoid cells in autoimmune diseases AS Clottu, M Humbel, N Fluder, MP Karampetsou, D Comte Frontiers in immunology 12, 789788, 2022 | 34 | 2022 |
| Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus MP Karampetsou, D Comte, K Kis-Toth, VC Kyttaris, GC Tsokos PloS one 12 (10), e0186073, 2017 | 31 | 2017 |
| Restoration of NK cell cytotoxic function with elotuzumab and daratumumab promotes elimination of circulating plasma cells in patients with SLE M Humbel, F Bellanger, N Fluder, A Horisberger, M Suffiotti, C Fenwick, ... Frontiers in Immunology 12, 645478, 2021 | 26 | 2021 |
| Impact of COVID-19 pandemic on SLE: beyond the risk of infection A Horisberger, L Moi, C Ribi, D Comte Lupus science & medicine 7 (1), e000408, 2020 | 26 | 2020 |
George TsokosHarvard Medical SchoolVerified email at bidmc.harvard.edu
